Diabetes Therapies Global Market Opportunities And Strategies To 2023, Including: Injectables, Oral, Covering: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Company, C.H. Boehringer Sohn AG & Ko. KG

Date: March 5, 2019
Pages: 150
Price:
US$ 4,000.00
License [?]:
Publisher: The Business Research Company
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D6FD4B92FB4EN
Leaflet:

Download PDF Leaflet

Diabetes Therapies Global Market Opportunities And Strategies To 2023, Including: Injectables, Oral, Covering: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Company, C.H. Boehringer Sohn AG & Ko. KG
Diabetes Therapies Global Market Opportunities And Strategies To 2023 report from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global diabetes therapies market.

Reasons to Purchase
  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
Description:

Where is the largest and fastest growing market for the diabetes therapies market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes therapies market opportunities and strategies to 2023 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters
  • Market Characteristics – The market characteristics section of the report defines and explains the diabetes therapies market. This chapter includes different goods and services covered in the report, basic definitions and market supply chain analysis.
  • Global Market Size And Growth – This section contains the global historic (2014-2018) and forecast (2018-2023) market value, and drivers and restraints that support and control the growth of the market in the historic and forecast period.
  • Trends And Strategies – This chapter includes some of the major trends shaping the global diabetes therapies market by segment. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Global Market Segmentation – This section contains global segmentation of the diabetes therapies market for 2018. Segmentation types include by region and by country segmentation of the diabetes therapies market.
  • Global Macro Comparison – The global diabetes therapies market comparison with macro-economic factors gives the diabetes therapies market size, percentage of GDP, and average diabetes therapies market expenditure.
  • Region/Country Market Size And Growth – This section contains the region’s market size (2018), historic (2014-2018) and forecast (2018-2023) market value, and growth. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa) and major countries within each region.
  • Competitive Landscape – This section covers details on the competitive landscape of the global diabetes therapies market, estimated market shares and company profiles for the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Opportunities And Strategies – This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Scope

Markets Covered: Injectables, Oral

Companies Mentioned: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Company, C.H. Boehringer Sohn AG & Ko. KG

Countries: China, Japan, India, Australia, USA, Brazil, UK, Germany, France, Spain, Italy, Russia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. EXECUTIVE SUMMARY

2. TABLE OF CONTENTS

3. LIST OF FIGURES

4. LIST OF TABLES

5. REPORT STRUCTURE

6. DIABETES THERAPIES MARKET CHARACTERISTICS

6.1. Market Definition
6.2. Diabetes Drugs

7. DIABETES THERAPIES MARKET SUPPLY CHAIN

8. DIABETES THERAPIES MARKET TRENDS AND STRATEGIES

8.1. Development of New Drugs for Diabetes-Associated Comorbidities
8.2. Increase in Partnerships and Collaborations
8.3. Increased Mergers and Acquisitions
8.4. Innovations

9. DIABETES THERAPIES MARKET SIZE AND GROWTH

9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.3. Drivers Of The Market 2014-18
9.4. Restraints On The Market 2014-18
9.5. Forecast Market Growth, Value ($ Billion)
9.6. Drivers Of The Market 2018-23
9.7. Restraints On The Market 2018-23
9.8. Global Diabetes Therapies Market, By Segment
9.9. Global Diabetes Therapies Market, Historic and Forecast CAGR, By Segment

10. DIABETES THERAPIES MARKET REGIONAL ANALYSIS

10.1. Global Diabetes Therapies Market, 2018, By Region, Value ($ Billion)
10.2. Global Diabetes Therapies Market, 2014 - 2023, Historic And Forecast, By Region
10.3. Global Diabetes Therapies Market, By Country
10.4. Global Diabetes Therapies Market, Historic and Forecast, By Country

11. DIABETES THERAPIES MARKET METRICS

11.1. Diabetes Therapies Market Size, Percentage Of GDP, Global
11.2. Per Capita Average Diabetes Therapies Expenditure, Global

12. ASIA-PACIFIC DIABETES THERAPIES MARKET

12.1. Asia Pacific Diabetes Therapies Market Overview
  12.1.1. Region Information
  12.1.2. Market Information
  12.1.3. Background Information
  12.1.4. Major End User Industries Information
  12.1.5. Regulations
  12.1.6. Associations
  12.1.7. Taxes Levied
  12.1.8. Corporate Tax Structure
  12.1.9. Collaborations and Partnerships in the Diabetes Therapies Market
  12.1.10. Investments and Funding in the Diabetes Therapies Market
  12.1.11. Major Companies
12.2. Asia-Pacific Diabetes Therapies Market, 2014 - 2023
12.3. Asia-Pacific Diabetes Therapies Market, By Segment
12.4. Asia-Pacific Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
12.5. Asia-Pacific Diabetes Therapies Market: Country Analysis
12.6. Chinese Diabetes Therapies Market, 2014-2023
12.7. Chinese Market Size, By Segment
12.8. Chinese Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
12.9. Indian Diabetes Therapies Market, 2014-2023
12.10. Indian Market Size, By Segment
12.11. Indian Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
12.12. Japanese Diabetes Therapies Market, 2014-2023
12.13. Japanese Market Size, By Segment
12.14. Japanese Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
12.15. Australia Diabetes Therapies Market, 2014-2023
12.16. Australia Market Size, By Segment
12.17. Australia Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment

13. WESTERN EUROPE DIABETES THERAPIES MARKET

13.1. Western Europe Diabetes Therapies Market Overview
  13.1.1. Region Information
  13.1.2. Market Information
  13.1.3. Background Information
  13.1.4. Major End User Industries Information
  13.1.5. Regulations
  13.1.6. Regulatory Bodies
  13.1.7. Associations
  13.1.8. Taxes Levied
  13.1.9. Corporate Tax Structure
  13.1.10. Collaborations and Partnerships in the Diabetes Therapies Market
  13.1.11. Investments and Funding in the Diabetes Therapies Market
  13.1.12. Major Companies
13.2. Western Europe Diabetes Therapies Market, 2014 - 2023
13.3. Western Europe Diabetes Therapies Market, By Segment
13.4. Western Europe Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
13.5. Western Europe Diabetes Therapies Market: Country Analysis
13.6. UK Diabetes Therapies Market, 2014-2023
13.7. UK Market Size, By Segment
13.8. UK Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
13.9. German Diabetes Therapies Market, 2014-2023
13.10. German Market Size, By Segment
13.11. German Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
13.12. France Diabetes Therapies Market, 2014-2023
13.13. French Market Size, By Segment
13.14. French Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
13.15. Italian Diabetes Therapies Market, 2014-2023
13.16. Italian Market Size, By Segment
13.17. Italian Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment
13.18. Spain Diabetes Therapies Market, 2014-2023
13.19. Spain Market Size, By Segment
13.20. Spain Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment

14. EASTERN EUROPE DIABETES THERAPIES MARKET

14.1. Eastern Europe Diabetes Therapies Market Overview
  14.1.1. Region Information
  14.1.2. Market Information
  14.1.3. Background Information
  14.1.4. Major End User Industries Information
  14.1.5. Regulations
  14.1.6. Regulatory Bodies
  14.1.7. Associations
  14.1.8. Taxes Levied
  14.1.9. Corporate Tax
  14.1.10. Investments and Funding in the Diabetes Therapies Market
  14.1.11. Major Companies
14.2. Eastern Europe Diabetes Therapies Market, 2014 - 2023
14.3. Eastern Europe Diabetes Therapies Market, By Segment
14.4. Eastern Europe Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
14.5. Eastern Europe Diabetes Therapies Market: Country Analysis
14.6. Russia Diabetes Therapies Market, 2014-2023
14.7. Russia Market Size, By Segment
14.8. Russia Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment

15. NORTH AMERICA DIABETES THERAPIES MARKET

15.1. North America Diabetes Therapies Market Overview
  15.1.1. Region Information
  15.1.2. Market Information
  15.1.3. Background Information
  15.1.4. Major End User Industries Information
  15.1.5. Regulations
  15.1.6. Regulatory Bodies
  15.1.7. Associations
  15.1.8. Taxes Levied
  15.1.9. Corporate Tax Structure
  15.1.10. Collaborations and Partnerships in the Diabetes Therapies Market
  15.1.11. Investments and Funding in the Diabetes Therapies Market
  15.1.12. Major Companies
15.2. North American Diabetes Therapies Market, 2014 - 2023
15.3. North American Diabetes Therapies Market, By Segment
15.4. North American Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
15.5. North American Diabetes Therapies Market: Country Analysis
15.6. USA Diabetes Therapies Market, 2014-2023
15.7. USA Market Size, By Segment
15.8. USA Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment

16. SOUTH AMERICA DIABETES THERAPIES MARKET

16.1. South America Diabetes Therapies Market Overview
  16.1.1. Region Information
  16.1.2. Market Information
  16.1.3. Background Information
  16.1.4. Major End User Industries Information
  16.1.5. Regulations
  16.1.6. Regulatory Bodies
  16.1.7. Associations
  16.1.8. Taxes Levied
  16.1.9. Corporate Tax Structure
  16.1.10. Investments and Funding in the Diabetes Therapies Market
  16.1.11. Major Companies
16.2. South American Diabetes Therapies Market, 2014 - 2023
16.3. South American Diabetes Therapies Market, By Segment
16.4. South American Diabetes Therapies Market, Historic and Forecast CAGR, By Segment
16.5. South American Diabetes Therapies Market: Country Analysis
16.6. Brazil Diabetes Therapies Market, 2014-2023
16.7. Brazil Market Size, By Segment
16.8. Brazil Diabetes Therapies Market, 2014-2023, Historic and Forecast, By Segment

17. MIDDLE EAST DIABETES THERAPIES MARKET

17.1. Middle East Diabetes Therapies Market Overview
  17.1.1. Region Information
  17.1.2. Market Information
  17.1.3. Background Information
  17.1.4. Major End User Industries Information
  17.1.5. Regulatory Bodies
  17.1.6. Associations
  17.1.7. Tax levied
  17.1.8. Corporate Tax Structure
  17.1.9. Collaborations and Partnerships in the Diabetes Therapies Market
  17.1.10. Major Companies
17.2. Middle East Diabetes Therapies Market, 2014 - 2023
17.3. Middle East Diabetes Therapies Market, By Segment
17.4. Middle East Diabetes Therapies Market, Historic and Forecast CAGR, By Segment

18. AFRICA DIABETES THERAPIES MARKET

18.1. Africa Diabetes Therapies Market Overview
  18.1.1. Region Information
  18.1.2. Market Information
  18.1.3. Background Information
  18.1.4. Major End User Industries Information
  18.1.5. Regulations
  18.1.6. Regulatory Bodies
  18.1.7. Associations
  18.1.8. Taxes Levied
  18.1.9. Corporate Tax Structure
  18.1.10. Investments and Funding in the Diabetes Therapies Market
  18.1.11. Major Companies
18.2. Africa Diabetes Therapies Market, 2014 - 2023
18.3. Africa Diabetes Therapies Market, By Segment
18.4. Africa Diabetes Therapies Market, Historic and Forecast CAGR, By Segment

19. DIABETES THERAPIES MARKET COMPETITIVE LANDSCAPE

  19.1.1. C.H. Boehringer Sohn AG & Ko. KG
  19.1.2. Johnson & Johnson
  19.1.3. Takeda Pharmaceutical Company Ltd.
  19.1.4. Sun Pharmaceutical Industries Limited
  19.1.5. Biocon Limited
19.2. Company Profiles
19.3. NOVO NORDISK A/S
  19.3.1. Company Overview
  19.3.2. Products And Services
  19.3.3. Product Overview
  19.3.4. Research and Development
  19.3.5. Collaborations and Partnerships
  19.3.6. New Product Launch
  19.3.7. Clinical Development
  19.3.8. Business Strategy
  19.3.9. Financial Overview
19.4. ELI LILLY AND COMPANY
  19.4.1. Company Overview
  19.4.2. Products And Services
  19.4.3. Product Overview
  19.4.4. Research and Development
  19.4.5. Collaborations and Partnerships
  19.4.6. New Product Launch
  19.4.7. Clinical Development
  19.4.8. Business Strategy
  19.4.9. Financial Overview
19.5. SANOFI S.A.
  19.5.1. Company Overview
  19.5.2. Products And Services
  19.5.3. Product Overview
  19.5.4. Research and Development
  19.5.5. Collaborations and Partnerships
  19.5.6. New Product Launch
  19.5.7. Clinical Development
  19.5.8. Business Strategy
  19.5.9. Financial Overview
19.6. MERCK & COMPANY, INC.
  19.6.1. Company Overview
  19.6.2. Products And Services
  19.6.3. Product Overview
  19.6.4. Research and Development
  19.6.5. Collaborations and Partnerships
  19.6.6. New Product Launch
  19.6.7. Clinical Development
  19.6.8. Business Strategy
  19.6.9. Financial Overview
19.7. C.H. BOEHRINGER SOHN AG & KO. KG
  19.7.1. Overview
  19.7.2. Products and Services
  19.7.3. Product Overview
  19.7.4. Research and Development
  19.7.5. Collaborations and Partnerships
  19.7.6. New Product Launch
  19.7.7. Clinical Development
  19.7.8. Business Strategy
  19.7.9. Financial Overview

20. KEY MERGERS AND ACQUISITIONS IN THE DIABETES THERAPIES MARKET

20.1. Takeda Pharmaceutical Acquired Shire
20.2. AstraZeneca Acquired Bristol-Myers Squibb’s Diabetes Business
20.3. PHC Holdings Acquired Bayer’s Diabetes Care Business
20.4. Eli Lilly Acquired Glycostasis
20.5. AstraZeneca Acquired ZS Pharma
20.6. Teva Acquired Allergan’s Generic Business

21. GLOBAL DIABETIC THERAPIES MARKET OPPORTUNITIES

21.1. Global Diabetic Therapies Market In 2023- Countries Offering Most New Opportunities
21.2. Global Diabetic Therapies Market In 2023- Segments Offering Most New Opportunities
  21.2.1. Injectables
  21.2.2. Oral

22. GLOBAL DIABETIC THERAPIES MARKET STRATEGIES

  22.1.1. Competitor Strategies

23. APPENDIX

23.1. Market Data Sources
23.2. Research Methodology
  23.2.1. Methodology
  23.2.2. Data
  23.2.3. Market Numbers
  23.2.4. Competitor Market Share Data
  23.2.5. Analysis
  23.2.6. Verification through Expert Interviews
  23.2.7. Referencing
Skip to top


Ask Your Question

Diabetes Therapies Global Market Opportunities And Strategies To 2023, Including: Injectables, Oral, Covering: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Company, C.H. Boehringer Sohn AG & Ko. KG
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: